Eosinophil-rich granulomatous panniculitis caused by exenatide injection-Reference-Cited by-同舟云学术

Eosinophil-rich granulomatous panniculitis caused by exenatide injection

Published:2013-11-14 Issue:1 Volume:41 Page:63-65
ISSN:0303-6987
Container-title:Journal of Cutaneous Pathology
language:en
Short-container-title:J Cutan Pathol

Author:

Boysen Nicholas C.¹,Stone Mary Seabury¹

Affiliation:

1. Department of Dermatology; University of Iowa Carver College of Medicine; Iowa City IA USA

Publisher

Wiley

Subject

Dermatology,Histology,Pathology and Forensic Medicine

Reference7 articles.

1. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor α receptor: Fc fusion protein;Zeltser;Arch Dermatol,2001

2. Cutaneous adverse events associated with disease-modifying treatment in multiple sclerosis: a systematic review;Balak;Multiple Sclerosis,2012

3. Cutaneous reactions to granulocyte-monocyte colony-stimulating factor;Mehregan;Arch Dermatol,1992

4. Cutaneous necrosis after injection of polyethylene glycol-modified interferon alfa;Dalmau;J Am Acad Dermatol,2005

5. Encapsulation of exenatide in poly-(d,l-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes;DeYoung;Diabetes Technol Ther,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare cutaneous adverse reactions associated with GLP-1 agonists: a review of the published literature;Archives of Dermatological Research;2024-05-25

2. GLP-1 agonists: A review for emergency clinicians;The American Journal of Emergency Medicine;2024-04

3. GLP-1RA Essentials in Gastroenterology: Side Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment;Gastroenterology Insights;2024-02-18

4. Eosinophil-related diseases during treatment with glucagon-like peptide one receptor (GLP-1 RA): a case report and review of the literature;Clinical Rheumatology;2023-05-18

5. Adverse drug reactions of GLP-1 agonists: A systematic review of case reports;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2022-03